HeyJaredMedspeak by CMJ
The Chinese Medical Journal (CMJ) reports the latest advances in medical sciences and technology. Hear the researchers who have published with CMJ talk about their most recent breakthroughs, and catch up on the latest updates in the field of medicine on the Medspeak by CMJ…
- Indexed episodes, last 90 days
- 1
- Latest publication
- Sep 22, 2026
- Audience
- Checking…
- Earliest in this view
- Sep 22, 2026
Latest episodes
Targeted Induction Therapy in Locally Advanced Lung Cancer—The Potential of ALK Inhibitors to Improve Surgical Outcomes, with Dr. Wen-zhao Zhong (opens the original)
Read excerpt
Targeted anaplastic lymphoma kinase (ALK) inhibitors offer significant advantages in the treatment of advanced non-small cell lung cancer (NSCLC) with ALK-fusion mutations. In this episode, we speak with Dr. Wenzhao Zhong, Vice President and Second-Level Professor at the Guangdong Provincial People’s Hospital, who presents new evidence from his study exploring the benefits of ALK-targeted induction therapy in stage III NSCLC. The study by Dr. Zhong and colleagues, published in the Chine...
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.